{
  "timestamp": "2026-01-05T07:11:52.297177",
  "agent_id": "medication_management",
  "phase": "complete",
  "input_data": null,
  "prompt": null,
  "llm_response": null,
  "output_data": {
    "clarification_needed": false,
    "clarification_question": "",
    "suggested_answer": "",
    "medications": [
      {
        "name": "Sertraline",
        "generic_name": "Sertraline",
        "brand_name": null,
        "strength": "50 mg",
        "form": "Tablet",
        "route": "Oral",
        "frequency": "Daily",
        "indication": "*Recurrent Major Depressive Disorder*",
        "response": "Minimal improvement noted after 4 weeks; patient reports persistent low mood, anhedonia, and early morning awakening.",
        "adherence": "Good (Taken every day, as reported)",
        "side_effects": []
      }
    ],
    "changes_made": [
      {
        "medication": "Sertraline",
        "change_type": "Increase Dose",
        "rationale": "Inadequate clinical response (persistent anhedonia, guilt, passive SI) after 4 weeks at the initial therapeutic dose. Dose increased from 50mg daily to 100mg daily to optimize treatment efficacy for *Recurrent Major Depressive Disorder*."
      }
    ],
    "peer_review_finding": "Diagnosis/Medication Alignment Check: **Match Confirmed**. *Sertraline* (SSRI) is standard first-line treatment for the proposed diagnosis of *Recurrent Major Depressive Disorder, Moderate (F33.1)*. No mismatch flagged."
  },
  "duration_ms": 6168,
  "error": null
}